21st International Conference on Emergency Medicine 2022

14 – 19 June

Hybrid Conference I Melbourne Convention and Exhibition Centre

21st International Conference on Emergency Medicine

14 – 19 June 2022

Hybrid Conference
Melbourne Convention and Exhibition Centre

21st International Conference on Emergency Medicine 2022

14 – 19 June

Hybrid Conference I Melbourne Convention and Exhibition Centre
PARTNER PROGRAM SPONSOR
07:00 – 08:15
THURSDAY 16 JUNE

BREAKFAST SESSION 3

Envenoming: from basic science to clinical realities

Australia is home to 20 of the 25 most venomous snakes worldwide, as well as some of the most venomous spiders and marine creatures. Presented by Seqirus, join a panel of experts for an interactive discussion on the evolutionary biology of Australia’s venomous creatures to explain the severe and clinically challenging envenoming syndromes observed in victims. Bridging the spectrum from basic to clinical science, this exchange of ideas will navigate the complexities of envenoming management across Australia. Panel members will present memorable and complex case studies with a toxinologic evolutionary twist including a discussion on clinical testing best practices and management. Join the panel members as they share their fascinating insights which we hope will provide inspiration for treating physicians.

Chair: Prof George Braitberg

Discussion Panel: A/Prof Bill Nimorakiotakis, Dr Jessamine Soderstrom, Dr Timothy Jackson

Seqirus has public health protection at its core, reflecting the promise of our parent company – CSL Limited – which was founded in 1916 to save lives and protect the health of people. Together with our partners on the front line, we have served Australia’s healthcare needs for over a century. Today we develop, manufacture and source medicines that support the health and well-being of many thousands of people around the world. Seqirus operates Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine, and produces a range of unique medicines in the national interest including antivenoms and Q fever vaccine.

Vyaire Medical Inc. is a global company, headquartered in suburban Chicago, focused exclusively on supporting breathing through every stage of life. Established from legacy brands with a 65-year history of pioneering breathing technology, the company’s portfolio of integrated solutions is designed to enable, enhance, and extend lives.

At Vyaire, our team of 4000, pledges to advance innovation and evolve what’s possible to ensure every breath is taken to its fullest. Vyaire’s products are available in more than 100 countries and are recognized, trusted, and preferred by specialists throughout the respiratory community worldwide.

Vyaire has a long and proud history with emergency care throughout Australia and beyond. As the home of legacy brands including Vital Signs, AirLife, enFlow, GreenLight, bellavista, and many more, we are your trusted partner every step in delivering emergency care.

Come speak to Vyaire to learn more about our innovative solutions in ventilation and respiratory care, and blood and fluid management in the ED.

COMPANY

Insert Bio

NAME

Face placeholder

Insert Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.